Total antihypertensive therapeutic intensity score and its relationship to blood pressure reduction

Journal of the American Society of Hypertension

Volumn 10, Issue 12, 2016, Pages 906-916

  Levy, Phillip D ^a   Willock, Robina Josiah ^b   Burla, Michael ^c   Brody, Aaron ^a   Mahn, James ^d   Marinica, Alexander ^a   Nasser, Samar A ^e   Flack, John M ^f  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MOREHOUSE SCHOOL OF MEDICINE   (United States)

^c OAKLAND UNIVERSITY WILLIAM BEAUMONT SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

^e GEORGE WASHINGTON UNIVERSITY   (United States)

^f SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antihypertensive therapy; hypertension; subclinical hypertensive heart disease

Indexed keywords

ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CALCIUM CHANNEL BLOCKING AGENT; CHLORTALIDONE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; SPIRONOLACTONE; THIAZIDE DIURETIC AGENT;

ADULT; AFRICAN AMERICAN; AGE; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE REGULATION; CLINICAL PROTOCOL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOSE RESPONSE; DRUG DOSE TITRATION; FEMALE; FOLLOW UP; HEART DISEASE; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE FUNCTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; THERAPEUTIC INTENSITY SCORE; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; COMPARATIVE STUDY; DIAGNOSTIC IMAGING; DRUG EFFECTS; ECHOCARDIOGRAPHY; HEART VENTRICLE; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; TREATMENT OUTCOME;

ADULT; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; ECHOCARDIOGRAPHY; FEMALE; HEART DISEASES; HEART VENTRICLES; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PRACTICE GUIDELINES AS TOPIC; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 85006172765     PISSN: 19331711     EISSN: 18787436     Source Type: Journal    
DOI: 10.1016/j.jash.2016.10.005     Document Type: Article

References (33)

1. 1 Egan, B.M., Zhao, Y., Axon, R.N., US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008. JAMA 303:20 (2010), 2043–2050.
2. 2 Ong, K.L., Cheung, B.M., Man, Y.B., Lau, C.P., Lam, K.S., Prevalence, awareness, treatment, and control of hypertension among United States adults 1999-2004. Hypertension 49:1 (2007), 69–75.
3. 3 Cutler, J.A., Sorlie, P.D., Wolz, M., Thom, T., Fields, L.E., Roccella, E.J., Trends in hypertension prevalence, awareness, treatment, and control rates in United States adults between 1988-1994 and 1999-2004. Hypertension 52:5 (2008), 818–827.
4. 4 Burt, V.L., Cutler, J.A., Higgins, M., Horan, M.J., Labarthe, D., Whelton, P., et al. Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population. Data from the health examination surveys, 1960 to 1991. Hypertension 26:1 (1995), 60–69.
5. 5 Fields, L.E., Burt, V.L., Cutler, J.A., Hughes, J., Roccella, E.J., Sorlie, P., The burden of adult hypertension in the United States 1999 to 2000: a rising tide. Hypertension 44:4 (2004), 398–404.
6. 6 Hajjar, I., Kotchen, T.A., Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA 290:2 (2003), 199–206.
7. 7 Gu, Q., Burt, V.L., Dillon, C.F., Yoon, S., Trends in antihypertensive medication use and blood pressure control among United States adults with hypertension: The National Health and Nutrition Examination Survey, 2001 to 2010. Circulation 126:17 (2012), 2105–2114.
8. 8 Bennett, H., Laird, K., Margolius, D., Ngo, V., Thom, D.H., Bodenheimer, T., The effectiveness of health coaching, home blood pressure monitoring, and home-titration in controlling hypertension among low-income patients: protocol for a randomized controlled trial. BMC Public Health, 9, 2009, 456.
9. 9 Berlowitz, D.R., Ash, A.S., Hickey, E.C., Friedman, R.H., Glickman, M., Kader, B., et al. Inadequate management of blood pressure in a hypertensive population. N Engl J Med 339:27 (1998), 1957–1963.
10. 10 Nelson, S.A., Dresser, G.K., Vandervoort, M.K., Wong, C.J., Feagan, B.G., Mahon, J.L., et al. Barriers to blood pressure control: a STITCH substudy. J Clin Hypertens (Greenwich) 13:2 (2011), 73–80.
11. 11 Pepine, C.J., Kowey, P.R., Kupfer, S., Kolloch, R.E., Benetos, A., Mancia, G., et al., INVEST Investigators. Predictors of adverse outcome among patients with hypertension and coronary artery disease. J Am Coll Cardiol 47:3 (2006), 547–551.
12. 12 Appel, L.J., Wright, J.T. Jr., Greene, T., Agodoa, L.Y., Astor, B.C., Bakris, G.L., et al. Intensive blood-pressure control in hypertensive chronic kidney disease. N Engl J Med 363:10 (2010), 918–929.
13. 13 The ACCORD Study Group, Cushman, W.C., Evans, G.W., Byington, R.P., Goff, D.C. Jr., Grimm, R.H. Jr., Cutler, J.A., et al. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med 362:17 (2010), 1575–1585.
14. 14 Ettehad, D., Emdin, C.A., Kiran, A., Anderson, S.G., Callender, T., Emberson, J., et al. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet 387:10022 (2016), 957–967.
15. 15 SPRINT Research Group, Wright, J.T., Williamson, J.D., Whelton, P.K., Snyder, J.K., Sink, K.M., Rocco, M.V., et al. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med 373:22 (2015), 2103–2116.
16. 16 Chobanian, A.V., Bakris, G.L., Black, H.R., Cushman, W.C., Green, L.A., Izzo, J.L. Jr., et al., Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 42:6 (2003), 1206–1252.
17. 17 James, P.A., Oparil, S., Carter, B.L., Cushman, W.C., Dennison-Himmelfarb, C., Handler, J., et al. Evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 311:5 (2014), 507–520.
18. 18 Lewis, L.M., Schoenthaler, A.M., Ogedegbe, G., Patient factors, but not provider and health care system factors, predict medication adherence in hypertensive black men. J Clin Hypertens (Greenwich) 14:4 (2012), 250–255.
19. 19 Swain, M.A., Steckel, S.B., Influencing adherence among hypertensives. Res Nurs Health 4:1 (1981), 213–222.
20. 20 Nasser, S.A., Lai, Z., O'Connor, S., Liu, X., Flack, J.M., Does earlier attainment of blood pressure goal translate into fewer cardiovascular events?. Curr Hypertens Rep 10:5 (2008), 398–404.
21. 21 Gil-Guillén, V., Orozco-Beltrán, D., Pérez, R.P., Alfonso, J.L., Redón, J., Pertusa-Martínez, S., et al. Clinical inertia in diagnosis and treatment of hypertension in primary care: quantification and associated factors. Blood Press 19:1 (2010), 3–10.
22. 22 Rose, A.J., Berlowitz, D.R., Manze, M., Orner, M.B., Kressin, N.R., Comparing methods of measuring treatment intensification in hypertension care. Circ Cardiovasc Qual Outcomes 2:4 (2009), 385–391.
23. 23 Dresser, G.K., Nelson, S.A., Mahon, J.L., Zou, G., Vandervoort, M.K., Wong, C.J., et al. Simplified therapeutic intervention to control hypertension and hypercholesterolemia: a cluster randomized controlled trial (STITCH2). J Hypertens 31:8 (2013), 1702–1713.
24. 24 Burla, M.J., Brody, A.M., Ference, B.A., Flack, J.M., Mahn, J.J., Marinica, A.L., et al. Blood pressure control and perceived health status in African Americans with subclinical hypertensive heart disease. J Am Soc Hypertens 8:5 (2014), 321–329.
25. 25 Levy, P., Ye, H., Compton, S., Zalenski, R., Byrnes, T., Flack, J.M., et al. Subclinical hypertensive heart disease in black patients with elevated blood pressure in an inner-city emergency department. Ann Emerg Med 60:4 (2012), 467–474.e1.
26. 26 Lawrence, W.F., Fryback, D.G., Martin, P.A., Klein, R., Klein, B.E., Health status and hypertension: a population-based study. J Clin Epidemiol 49:11 (1996), 1239–1245.
27. 27 Nagueh, S.F., Appleton, C.P., Gillebert, T.C., Marino, P.N., Oh, J.K., Smiseth, O.A., et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiogr 22:2 (2009), 107–133.
28. 28 Brody, A., Rahman, T., Reed, B., Millis, S., Ference, B., Flack, J.M., et al. Safety and efficacy of antihypertensive prescription at emergency department discharge. Acad Emerg Med 22:5 (2015), 632–635.
29. 29 Ho, P.M., Magid, D.J., Shetterly, S.M., Olson, K.L., Peterson, P.N., Masoudi, F.A., et al. Importance of therapy intensification and medication nonadherence for blood pressure control in patients with coronary disease. Arch Intern Med 168:3 (2008), 271–276.
30. 30 Law, M.R., Wald, N.J., Morris, J.K., Jordan, R.E., Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials. BMJ, 326(7404), 2003, 1427.
31. 31 Okonofua, E.C., Simpson, K.N., Jesri, A., Rehman, S.U., Durkalski, V.L., Egan, B.M., Therapeutic inertia is an impediment to achieving the Healthy People 2010 blood pressure control goals. Hypertension 47:3 (2006), 345–351.
32. 32 Charlson, M.E., Pompei, P., Ales, K.L., MacKenzie, C.R., A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40 (1987), 373–383.
33. 33 Toussaint, J., Milstein, A., Shortell, S., How the Pioneer ACO Model needs to change: lessons from its best-performing ACO. JAMA 310:13 (2013), 1341–1342.